Surgery results in greater improvement in weight loss outcomes and weight associated comorbidities compared with non-surgical interventions , regardless of the type of procedures used .
When compared with each other , certain procedures result ed in greater weight loss and improvements in comorbidities than others .
Outcomes were similar between RYGB and sleeve gastrectomy , and both of these procedures had better outcomes than adjustable gastric b and ing .
For people with very high BMI , biliopancreatic diversion with duodenal switch result ed in greater weight loss than RYGB .
Isolated sleeve gastrectomy led to better weight-loss outcomes than adjustable gastric b and ing after three years follow-up .
BACKGROUND Bariatric ( weight loss ) surgery for obesity is considered when other treatments have failed .
The effects of the available bariatric procedures compared with medical management and with each other are uncertain .
This is an up date of a Cochrane review first published in 2003 and most recently up date d in 2009 .
OBJECTIVES To assess the effects of bariatric surgery for overweight and obesity , including the control of comorbidities .
Gastroesophageal reflux disease and esophageal motility in morbidly obese patients submitted to laparoscopic adjustable silicone gastric banding or laparoscopic vertical banded gastroplasty
Background Laparoscopic adjustable silicone gastric b and ing ( LASGB ) and laparoscopic vertical b and ed gastroplasty ( LVBG ) are the most frequently performed restrictive operations for morbid obesity . The question of whether bariatric restrictive procedures increase or reduce gastroesophageal reflux disease ( GERD ) remains open . This study aim ed to compare the long-term results of LASGB with those of LVBG in terms of postoperative GERD and esophageal motility function . Methods From February 1999 to December 2000 , 175 patients underwent bariatric surgery .  After 75 of these patients were excluded from the study , the remaining 100 patients were r and omly assigned to one of two treatment groups : LASGB or LVBG . The end points of the study were evaluation of clinical and instrumental GERD and esophageal function . The follow-up protocol included clinical assessment using the Gastroesophageal Reflux Health-Related Quality -of-Life ( GERD-HRQOL ) scale at 3 , 12 , and 96 months . Esophageal manometry , 24-h pH monitoring , and endoscopy  were performed at 12 and 96 months . Results At 12 months , GERD had developed in 13 ( 26 % ) LASGB and 11 ( 21.6 % ) LVBG patients . In the majority of cases , GERD result ed from pouch dilation or poor compliance and required either reoperation ( ten after LASGB and three after LVBG ) or endoscopic dilation of the neopylorus ( four after LVBG ) . In all , 71 patients completed the 96-month follow-up protocol . The findings showed that three ( 11.5 % ) of 26 LASGB patients and four ( 9 % ) of 45 LVBG patients were receiving proton pump inhibitor ( PPI ) therapy for GERD . Postoperative lower esophageal sphincter ( LES ) pressure and esophageal motility did not differ from preoperative data except for the presence of aperistaltic waves in one LASGB and two LVBG symptomatic GERD patients . Conclusions No significant association between gastric restrictive procedures and GERD or esophageal function was found during long-term follow-up assessment . The increased occurrence of GERD in the early follow-up period often is due to a technical defect or poor patient compliance
Surgery results in greater improvement in weight loss outcomes and weight associated comorbidities compared with non-surgical interventions , regardless of the type of procedures used .
When compared with each other , certain procedures result ed in greater weight loss and improvements in comorbidities than others .
Outcomes were similar between RYGB and sleeve gastrectomy , and both of these procedures had better outcomes than adjustable gastric b and ing .
For people with very high BMI , biliopancreatic diversion with duodenal switch result ed in greater weight loss than RYGB .
Isolated sleeve gastrectomy led to better weight-loss outcomes than adjustable gastric b and ing after three years follow-up .
BACKGROUND Bariatric ( weight loss ) surgery for obesity is considered when other treatments have failed .
The effects of the available bariatric procedures compared with medical management and with each other are uncertain .
This is an up date of a Cochrane review first published in 2003 and most recently up date d in 2009 .
OBJECTIVES To assess the effects of bariatric surgery for overweight and obesity , including the control of comorbidities .